Hwaseong, South Korea

Hanmi Pharmaceutical Co., Ltd.

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 25.0



Forward Citations = 11

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Young Gil Ahn (3 out of 23 patents)

silverMedal Seung Hyun Jung (3 out of 8 patents)

bronzeMedal Seo Hee Kim (2 out of 6 patents)

4.  Ji Young Hwang (2 out of 2 patents)

5.  Dong Jin Hong (2 out of 2 patents)

6.  Ji Young Song (1 out of 10 patents)

7.  Seok Jong Kang (1 out of 10 patents)

8.  Gwan Sun Lee (1 out of 44 patents)

9.  Tae Hee Ha (1 out of 17 patents)

10.  Nam Du Kim (1 out of 5 patents)

11.  Young Jin Ham (1 out of 13 patents)

12.  Guru Reddy (1 out of 14 patents)

13.  Eun Young Byun (1 out of 4 patents)

14.  Seung Ah Jun (1 out of 4 patents)

15.  Ji Sook Kim (1 out of 12 patents)


8 patents:

Company Overview
Hanmi Pharmaceutical Co., Ltd. is a leading South Korean pharmaceutical company dedicated to developing innovative and affordable medications. With a focus on research and development, Hanmi Pharmaceutical strives to improve global healthcare through the creation of high-quality pharmaceutical products. The company is committed to fostering partnerships and collaborations in order to expand its reach and impact in the pharmaceutical industry.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#23 in Hwaseong

#1,307 in South Korea

Hwaseong, KR
Hwaseong, South Korea
Forward Citations = 11

32 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hanmi Pharmaceutical Co., Ltd.. Retrieved from https://idiyas.com/company/hanmi-pharmaceutical-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…